Vina Biocare Vietnam was honored to accompany the successful scientific and technical workshop held at the Central Psychiatric Hospital No. 2 on July 30, 2025.

We would like to express our sincere gratitude to the Hospital Board of Directors, departments, and more than 100 doctors, pharmacists, and medical staff from various units for their enthusiastic support, cooperation, and full participation, which contributed to the success of the event and provided practical knowledge for patient care and community health improvement.

This event was a valuable opportunity for Vina Biocare to introduce advanced medical solutions that contribute to the screening and early detection of dementia risks. It also reaffirmed our commitment to working alongside healthcare professionals to enhance community health. With its non-invasive nature, affordable cost, and early detection capability, the ONE STEP DEMENTIA RISK TEST KIT (Qualitative Amyloid Beta Protein Test Cassette) serves as an important tool for screening and supporting the diagnosis of Alzheimer’s dementia risk — a crucial step toward early intervention for these conditions.

In the future, Vina Biocare is committed to delivering the most advanced solutions and products to improve the healthcare of Vietnamese people.